Back

Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Atrial fibrillation obesity Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Tymon Pol

Uppsala University, Uppsala (Sweden)

14 More presentations in this session

Presentation thumbnail
Doctor T. Liu (Tianjin, CN)
Presentation thumbnail
Ms J. Neefs (Amsterdam, NL)
Abstract
Presentation thumbnail
Assistant Professor V. Ionin (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Doctor A. Ott (Barnaul, RU)
Abstract Slides
Presentation thumbnail
Doctor S. Goldhaber (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Atrial fibrillation obesity

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources